Lineage Cell Therapeutics (LCTX) Cash & Equivalents (QoQ) (2010 - 2026)
Lineage Cell Therapeutics (LCTX) Cash & Equivalents (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Lineage Cell Therapeutics | 254.83 Mn | 192.11 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.50% |
| Dec 31, 2025 | 42.66% |
| Sep 30, 2025 | -23.78% |
| Jun 30, 2025 | -11.73% |
| Mar 31, 2025 | 16.74% |
| Dec 31, 2024 | 47.81% |
| Sep 30, 2024 | -6.32% |
| Jun 30, 2024 | -32.02% |
| Mar 31, 2024 | 45.57% |
| Dec 31, 2023 | -4.89% |
| Sep 30, 2023 | -7.12% |
| Jun 30, 2023 | 119.31% |
| Mar 31, 2023 | 36.07% |
| Dec 31, 2022 | -54.12% |
| Sep 30, 2022 | -65.07% |
| Jun 30, 2022 | -9.23% |
| Mar 31, 2022 | 40.04% |
| Dec 31, 2021 | -8.33% |
| Sep 30, 2021 | -1.92% |
| Jun 30, 2021 | 10.30% |